2021-22 Academic Calendar (PDF)
« All Events
Join us as Master of Science in Applied Life Sciences student Utkarsha Paithane speaks about genes involved in adaptive resistance to Erlotinib.
Lung cancer is one of the most common cancers in the world, with 80% of them being non-small cell lung cancer (NSCLC). The current treatment for metastatic lung cancer is anti-cancer chemotherapy targeted against the specific molecular form of cancer determined through molecular typing of the cancer tissues; however, patients often relapse due to drug resistance. Identification of the genes that contribute to chemotherapy resistance will help in understanding the mechanisms by which the cells adapt themselves to drugs. This can then be applied to drug development so that drugs can be made while keeping in mind the genes and how they contribute to cells becoming resilient against the drug.
Date: Friday, November 1, 2019 at 12:00 p.m.
Location: Building 121, 1110 Classroom
Snacks will be provided. Please feel free to bring your own lunch to eat during the seminar.